Aegirbio Ownership

AEGIR Stock  SEK 0.62  0.03  5.08%   
Aegirbio AB retains a total of 21.28 Million outstanding shares. Aegirbio AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Some institutional investors establish a significant position in stocks such as Aegirbio in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Aegirbio, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aegirbio AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Aegirbio Stock Ownership Analysis

About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.29. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aegirbio AB recorded a loss per share of 5.77. The entity had not issued any dividends in recent years. The firm had 3601:3304 split on the 8th of June 2022. AegirBio AB , a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company was incorporated in 2019 and is based in Lund, Sweden. AegirBio is traded on Stockholm Stock Exchange in Sweden. For more info on Aegirbio AB please contact Bradley Messmer at 46 4 62 86 54 00 or go to https://aegirbio.com.

Pair Trading with Aegirbio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aegirbio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aegirbio will appreciate offsetting losses from the drop in the long position's value.

Moving against Aegirbio Stock

  0.6GETI-B Getinge AB serPairCorr
  0.48SEDANA Sedana Medical ABPairCorr
  0.48FLNGO Flex LNGPairCorr
  0.47BONEX Bonesupport HoldingPairCorr
The ability to find closely correlated positions to Aegirbio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aegirbio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aegirbio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aegirbio AB to buy it.
The correlation of Aegirbio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aegirbio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aegirbio AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aegirbio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aegirbio AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Aegirbio Stock analysis

When running Aegirbio's price analysis, check to measure Aegirbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aegirbio is operating at the current time. Most of Aegirbio's value examination focuses on studying past and present price action to predict the probability of Aegirbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aegirbio's price. Additionally, you may evaluate how the addition of Aegirbio to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Please note, there is a significant difference between Aegirbio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aegirbio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aegirbio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.